JC

John Curnutte

Board of Directors - Orchard Therapeutics; Board of Directors - Pliant Therapeutics; Consultant at Portola Therapeutics

San Francisco Bay Area

Investor
VC

Invests in

Stages:

Seed

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $100,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Translational Medicine
Inflammation
Biotechnology
R&D
Cell Biology
Biopharmaceuticals
Assay Development
Clinical Development
Drug Development
Biochemistry
Clinical Trials

Education

Lists including John

AH
AE
AF
AJ

Based in SF

3077 people

AM
AT
AS
AR

All Seed Investors

19691 people

Work Experience

N
Neuvivo

2025

  • Board Member

    2025

CB
Cayuga Biotech

2024

  • Board Member

    2024

SB
Samsara BioCapital

2020

  • Senior Advisor

    2020

AL
Autobahn Labs, Inc.

2020

  • SAB Member

    2020

PT
Pliant Therapeutics

2017

  • Board of Directors Member

    2017

OT
Orchard Therapeutics

2019 - 2024

  • Board Member

    2019 - 2024

PP
Portola Pharmaceuticals

2011 - 2020

  • Consultant

    2019 - 2020

  • Executive Vice President of Research & Development

    2011 - 2019

3B
3-V Biosciences

2008 - 2010

  • CEO

    2008 - 2010

Schering-Plough Biopharma (formerly DNAX Research Institute)

2000 - 2008

  • President

    2000 - 2008

Genentech

1993 - 2000

  • Senior Director, Department of Immunology

    1993 - 2000